Patents
Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
06/2003
06/05/2003US20030104974 Dual inhibitorsof PDE 7 and PDE 4
06/05/2003US20030104500 Enzymatic assays for screening anti-cancer agents
06/05/2003US20030104406 Modified and stabilized GDF propeptides and uses thereof
06/05/2003US20030104403 Nucleotide sequence coding transferase enzyme for use in treatment cancer
06/05/2003US20030104077 Relieving symptoms of erectile dysfunction with proanthocyanidins
06/05/2003CA2468717A1 Aryl fused azapolycyclic compounds
06/05/2003CA2468705A1 Succinic acid salts of 5,8,14-triazatetracyclo'10.3.1.0<2,11>.0<4,9>-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
06/05/2003CA2468240A1 Muscle transcription factors
06/05/2003CA2468015A1 2-aminoquinoline compounds
06/05/2003CA2467892A1 Methods and compositions for derepression of iap-inhibited caspase
06/05/2003CA2467825A1 Benzothiazole derivatives
06/05/2003CA2466870A1 Methods for treating autoimmune disorders, and reagents related thereto
06/05/2003CA2466845A1 Manipulation of cytokine levels using cd83 gene products
06/04/2003EP1315800A2 Human proteases
06/04/2003EP1315758A2 Methods and reagents for protease inhibition
06/04/2003EP1315735A1 Phosphate derivatives as immunoregulatory agents
06/04/2003EP1315502A1 Method for treating erectile dysfunction and increasing libido in men
06/04/2003EP1252150B1 Heterocyclic derivatives, preparation method and pharmaceutical compositions containing same
06/04/2003EP1155014B1 New benzimidazole compounds for use as active therapeutic substances, process for the preparation of these compoudns and pharmaceutical compositions comprising them
06/04/2003EP0789578B1 Multicatalytic protease inhibitors
06/04/2003EP0775118B1 Benzimidazole derivatives having dopaminergic activity
06/04/2003EP0665752B1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives, and use thereof
06/04/2003EP0606366B1 Substituted phenserines and phenylcarbamates of (-)-eseroline, (-)-n1-noreseroline, and (-)-n1-benzylnoreseroline; as specific inhibitors of acetylcholinesterase
06/04/2003CN1422273A 1,5-disubstituted-3,4-dihydro-1H-pyrimido [4,5-D] pyrimidi-2-one compounds and their use in treating CSBP/P38 kinase mediated diseases
06/04/2003CN1422260A 2-guanidino-4-arylchinazolines as NHE-3 inhibitors
06/04/2003CN1110499C Spiro-quinuclidine derivatives, their preparation and use
06/03/2003US6573264 Heteroaryl alkyl piperazine derivatives
06/03/2003US6573243 Pompilid wasp-derived neuropeptides
06/03/2003US6572858 Uses for anti-malarial therapeutic agents
05/2003
05/30/2003WO2003044170A2 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
05/30/2003WO2003044021A2 Substituted indolizine-like compounds and methods of use
05/30/2003WO2003044010A1 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with tnf activity
05/30/2003WO2003043651A1 Drug mobilizing pluripotent stem cells from tissue into peripheral blood
05/30/2003WO2003043634A1 Benzothiazole derivatives as adenosine receptor ligands
05/30/2003WO2003043619A1 New use for the treatment of gastroesophageal reflux disease
05/30/2003WO2003027248A3 Antibody inhibitors of gdf-8 and uses thereof
05/30/2003WO2003008448A3 Novel human proton-gated channels
05/30/2003WO2003005998A3 A pharmaceutical composition comprising a nicotinic receptor partial antagonist and an antiemetic agent of modulating cholinergic function
05/30/2003WO2002096363A3 Method for treating fibrotic diseases or other indications
05/30/2003WO2002088100A3 Deuterated 3-piperidinopropiophenone and medicaments containing said compounds
05/30/2003CA2467557A1 Agent which mobilizes multipotential stem cells from tissues to peripheral blood
05/30/2003CA2467551A1 Benzothiazole derivatives as adenosine receptor ligands
05/30/2003CA2466916A1 New use for the treatment of gastroesophageal reflux disease
05/30/2003CA2466072A1 Substituted indolizine-like compounds and methods of use
05/30/2003CA2463790A1 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
05/29/2003US20030100609 Orally ingesting a quantity of calcium formate sufficient to improve calcium balance or retention
05/29/2003US20030100607 Thiolalkyl benzoic acid derivatives
05/29/2003US20030100603 Administering to the patient subject to a C-reactive protein associated inflammatory condition, an effective amount of a non-alpha-tocopherol enriched tocopherol
05/29/2003US20030100594 Carbonic anhydrase inhibitor
05/29/2003US20030100577 Neurotrophic agents in treatment of solid tumors and vascular disease
05/29/2003US20030100574 Tricyclic 3,4-propinoperhydropurines; uses thereof for blocking neuronal transmission
05/29/2003US20030100571 Such as 2-((6-(((4-(3,4-dimethoxyphenyl)methyl)amino)-7-ethyl-7H-purin-2-yl)amino) -4,5-methyl-N-phenyl-5-thiazole-carboxamide for treatment of lymphocyte mediated diseases such as transplant rejection and graft versus host disease
05/29/2003US20030100570 Immunomodulation and effect on cell processes relating to serotonin family receptors
05/29/2003US20030100542 5-hydroxysapogenin derivatives with anti-dementia activity
05/29/2003US20030099694 Method for the improvement of transport across adaptable semi-permeable barriers
05/28/2003EP1314980A2 A system for cell-based screening
05/28/2003EP1314723A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
05/28/2003EP1314719A1 Benzoic acid derivatives and drugs containing the same as the active ingredient
05/28/2003EP1314426A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
05/28/2003EP1313854A2 Transporters and ion channels
05/28/2003EP1313840A2 Isolated human drug-metabolizing proteins, nucleic acid molecules and uses thereof
05/28/2003EP1313710A1 Pyrazole derivatives and their use as protein kinase inhibitors
05/28/2003EP1313707A1 Quinoline derivatives as anti-inflammation agents
05/28/2003EP1313705A1 Gem-substituted alpha v beta 3 integrin antagonists
05/28/2003EP1313496A1 Use of a composition comprising an extract of pollen for the treatment of edema
05/28/2003EP1313495A1 Use of a composition comprising an extract of pollen for the treatment of hormonally-related disorders
05/28/2003EP1313494A1 Use of a composition comprising an extract of pollen for the treatment of disease-related weight gain
05/28/2003EP1313493A1 Use of a composition comprising an extract of pollen for the treatment of irritability
05/28/2003EP1313492A1 Use of a composition comprising an extract of pollen for the treatment of dysphoria
05/28/2003EP0786995B1 Use of 5-(tetradecyloxy)-2-furan carboxylic acid for treating alzheimer's disease or psychosis
05/28/2003CN1420881A Beta-amino acid derivs. as inhibitors of matrix metalloproteases and TNF-alpha
05/28/2003CN1420878A Compound with growth hormone releasing properties
05/28/2003CN1420872A Caspase inhibitors and use thereof
05/28/2003CN1420870A Modulators of dopamine neurotransmission
05/28/2003CN1420770A Method of delivery of cetyl myristoleate
05/27/2003US6569855 Particularly zinc metalloprotease activity for treatment of variety of maladies involving inflammation and/or tissue integrity
05/27/2003US6569847 Inhibitors of cathepsins for treating muscular dystrophy, osteoporosis, rheumatoid arthritis, neuronal or cardiac ischaemia, allergy, or Chagas disease
05/27/2003US6569842 Method of preparing and use of prodrugs of betulinic acid derivatives
05/27/2003US6569468 Treatment of urogenital disorders, menstrual cramps
05/27/2003US6569463 Encapsulation coat includes different combinations of pharmaceutical active ingredients, hydrophilic and lipophilic surfactants, and triglycerides
05/27/2003CA2412624A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurogenerative diseases
05/27/2003CA2412466A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
05/22/2003WO2003042405A2 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof
05/22/2003WO2003042397A2 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
05/22/2003WO2003042205A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5)
05/22/2003WO2003042197A1 Oligopeptides and compositions containing them as cathepsin s inhibitors
05/22/2003WO2003042191A1 Benzamide and heteroarylamide as p2x7 receptor antagonists
05/22/2003WO2003042190A1 N-alkyl-adamantyl derivatives as p2x7-receptor antagonists
05/22/2003WO2003042113A1 Production of cell suspensions
05/22/2003WO2003041715A1 Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer
05/22/2003WO2003041713A1 Use of therapeutic dosages for nitric oxide donors which do not significantly lower blood pressure or pulmonary artery pressure
05/22/2003WO2003041697A1 Method for treating autoimmune diseases
05/22/2003WO2003041684A2 Injectable depot compositions and uses thereof
05/22/2003WO2003041649A2 Cyanoalkylamino derivatives as protease inhibitors
05/22/2003WO2002096362A3 Method for treating fibrotic diseases or other indications vi
05/22/2003WO2002045749A8 Methods for stimulating nervous system regeneration and repair by inhibition phosphodiesterase type 4
05/22/2003WO2002044183A3 Benzoazepine and benzodiazepine derivatives and their use as parp inhibitors
05/22/2003US20030096873 Administering therapeutically effective amount of (+)-bupropion or a pharmaceutically acceptable salt thereof, substantially free of its (-)-stereoisomer for therapy of pain
05/22/2003US20030096844 Cannabinoid receptor ligands
05/22/2003US20030096838 Novel triazolo-pyridines anti-inflammatory compounds